Cross-omics analysis revealed gut microbiome-related metabolic pathways underlying atherosclerosis development after antibiotics treatment

• Main Authors: Ben Arpad Kappel (Author), Lorenzo De Angelis (Author), Michael Heiser (Author), Marta Ballanti (Author), Robert Stoehr (Author), Claudia Goettsch (Author), Maria Mavilio (Author), Anna Artati (Author), Omero A. Paoluzi (Author), Jerzy Adamski (Author), Geltrude Mingrone (Author), Bart Staels (Author), Remy Burcelin (Author), Giovanni Monteleone (Author), Rossella Menghini (Author), Nikolaus Marx (Author), Massimo Federici (Author)
• Format: Book
• Published: Elsevier, 2020-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: The metabolic influence of gut microbiota plays a pivotal role in the pathogenesis of cardiometabolic diseases. Antibiotics affect intestinal bacterial diversity, and long-term usage has been identified as an independent risk factor for atherosclerosis-driven events. The aim of this study...